Seagen

$168.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$5.34 (-3.08%) Today
$0.00 (0.00%) As of 9:57 PM UTC after-hours

Why Robinhood?

You can buy or sell Seagen and other stocks, options, and ETFs commission-free!

About SGEN

Seagen Inc. Common Stock, also called Seagen, is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. The listed name for SGEN is Seagen Inc. Common Stock.

CEO
Clay B. Siegall
Employees
1,605
Headquarters
Bothell, Washington
Founded
1997
Market Cap
30.30B
Price-Earnings Ratio
68.19
Dividend Yield
Average Volume
940.75K
High Today
$174.33
Low Today
$166.88
Open Price
$173.95
Volume
1.10M
52 Week High
$213.94
52 Week Low
$90.57

Collections

SGEN Earnings

-$0.98
-$0.34
$0.30
$0.94
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 4, After Hours

You May Also Like